Image Credit: Canva (representational purpose only)
Mysterious Fog in the US , Canada and UK: A dense, eerie fog with a "burning chemical-like smell" has spooked a good part of North America and parts of the United Kingdom and Canada. With social media amplifying all concerns, this phenomenon has sparked attention across all social media platforms. However, at the heart of this mysterious fog are a conjunction of natural events, social psychology, and environmental conditions that culminated in all the conspiracy theories and public health fears. Here's a closer look at the mysterious fog, its potential causes, and the societal response it has triggered.
The first reports of this "mysterious fog" came in from Florida where a resident said that they experienced respiratory symptoms, feverish warmth, and stomach cramps after contact with the fog. Similar stories started flooding social media, and within a day or two, a sinister force seemed to sweep across the United States, Canada, and parts of the UK. From Texas to Minnesota, people reported weird odors and health issues that they thought were linked to this bizarre atmospheric event.
Some witnesses were said to see "white particles" swirling through the air; theories ranged from a chemical attack or experimental weapon to drone-related chemical dispersals and references to historical military experiments, such as the infamous 1950s "Operation Sea-Spray."
Fuel to the fire were added when videos and posts, hundreds of thousands in number, began circulating on social media sites like TikTok and X (formerly Twitter) speculating on the origin of the fog. Hashtags like #ToxicFog went trending for days. Hysteria created a self-reinforcing loop in which every post spurred further scrutiny and fear.
Fog is essentially a low-lying cloud formed when the air temperature cools to its dew point, causing water vapor to condense into tiny droplets or ice crystals. Several types of fog—advection fog, radiation fog, and valley fog—can form depending on conditions such as warm, moist air moving over cooler land or when temperatures plummet rapidly under clear skies.
Such chemical-like smell as reported during the occurrence of fog events is sometimes attributed to air pollution. It acts like a sponge, where it absorbs these pollutants, which include sulfur dioxide and nitrogen oxides, among others, that emit from industries. This mixture, therefore, leads to a stench that could be mistaken as unnatural or even toxic.
Also Read: Health Concerns Rise As US, Canada, and UK Come Under The Blanket Of Thick, Dense, Toxic Fog
High moisture levels from fog can significantly exacerbate symptoms related to respiration, but especially in already predisposed asthmatics and allergy patients. The connection of these symptoms with actual fever, stomach cramps, and puffy eyes is too remote. Experts assume that the irritating effects of entrapped pollutants trapped in fog tend to affect more the eyes and throat rather than the rest of the body affected by some report.
Social media amplified a natural weather event into a health epidemic. It made the personal experience of individuals become a cause for fear and speculation, a domino effect.
According to psychologists, this is a concept of selective perception, wherein once people's attention is drawn to environmental anomalies, they begin to notice them. This mirrors earlier panics, such as the Seattle windshield pitting panic of 1954. Then, atomic bomb testing caused fear in many and started to have people looking at their windshields for small marks that they had not seen before. Likewise, postings on the strangeness of the fog probably increased public awareness and suspicion, with people looking to attach unrelated symptoms to the phenomenon.
The fog hysteria shares a commonality with other instances of mass panic, such as the "drone sightings" of recent years or the Cold War-era fears of biological warfare.
Also Read: Mysterious Fog Is Making Americans Sick
These events underscore how fear can cloud judgment, especially when amplified by social media and sensationalist headlines. While historical cases, such as "Operation Sea-Spray," offer concrete evidence of the existence of unethical experiments, the jump from a natural weather condition to theories of chemical attacks exemplifies a more modern trend of connecting unrelated dots, all wonderfully seeded in distrust and anxiety.
Despite the swirling rumors, meteorologists and scientists are in agreement that the mysterious fog is not as alarming as it seems. It is well known that fog traps and amplifies pollutants, especially in urban and industrial regions. Moreover, winter months are the most conducive for fog formation, so its recent prevalence is unsurprising.
On the other hand, environmentalists advise that the fog should wake everyone up to increased levels of pollution. The reported odors and health irritations could be just symptoms of far deeper systemic issues like industrial emissions and lack of control over air quality.
The authorities must be transparent in their communication to combat misinformation and allay public fears. Governments and environmental agencies must provide timely updates on weather phenomena, air quality, and health risks. Initiatives like real-time pollutant tracking and public education campaigns can help demystify natural occurrences while addressing valid environmental concerns.
The mysterious Canada fog is a compelling case study in how environmental events intersect with psychology and societal dynamics. While rooted in natural phenomena, the fog became a vessel for collective fears, amplified by modern technology and historical anxieties.
In this information era where communication occurs at an almost lightning pace, the fog becomes a metaphor that reminds everyone about scientific literacy, environmental responsibility, and an effective balance when considering public concern. Whether perceived as a marvel of nature or as a tale that serves to teach, it left a very powerful mark in people's minds.
Credit: iStock
While GLP-1 drugs such as Ozempic, Wegovy and Zepbound are helping with weight loss and diabetes management, men already at risk of androgenetic alopecia may face a 7% higher risk of hair loss with higher GLP-1 activity, according to a new study.
Hair thinning has been reported by both men and women using GLP-1 drugs, with researchers largely attributing the shedding to rapid weight loss associated with the medications.
However, researchers at NYU Langone Health have now identified a potential genetic link between GLP-1 activity and androgenetic alopecia, an inherited form of hair loss affecting the top and front of the scalp.
"Our study provides the first genetic link between GLP-1 use and an increased risk of male-pattern hair loss from androgenetic alopecia, an association long suspected but until now not shown scientifically," said Lynn Petukhova, assistant professor in the Department of Dermatology and the Department of Population Health at NYU Grossman School of Medicine.
Researchers used large, publicly available genetic databases, including:
The researchers compared GLP1R-related genetic data with markers associated with androgenetic alopecia. They found that genetic variants linked to naturally higher levels of GLP-1 receptor proteins were more common in men with androgenetic alopecia.
The team also adjusted the analysis for hypertension, which may affect blood flow to the scalp and hair follicle growth; and accounted for insulin resistance and lower testosterone levels.
After these adjustments, the 7% higher risk remained.
Published online in the Journal of Investigative Dermatology, the findings suggest that GLP-1 activity and male-pattern hair loss may share a biological link.
The findings could eventually help identify people who may be more vulnerable to hair loss before they are prescribed GLP-1 medications.
"Our findings suggest that, if future experiments prove successful, some men, and possibly women too, could be screened and benchmarked for their risk of hair loss before being prescribed GLP-1 medications," Petukhova said.
The researchers also suggested that some GLP-1 users could potentially receive combination treatments to prevent hair loss, such as minoxidil or another drug.
However, more research is needed to understand how GLP-1 activity may affect hair follicle growth. Petukhova also plans to investigate whether the genetic link seen in men applies to women.
Hair shedding has been reported among GLP-1 users and has been linked by researchers to rapid weight loss.
In many cases, hair growth resumes several months after weight stabilizes.
The new findings add a potential genetic explanation to these reports, but further research is needed to establish the underlying biological mechanism.
What Is Androgenetic alopecia?
Androgenetic alopecia is a common form of hair loss that becomes more likely with age. It can begin as early as the teenage years and affects both men and women, with hair loss in women most commonly observed after menopause.
Surveys suggest that 12% of Americans have used GLP-1 drugs specifically for weight loss, including one-fifth of women aged 50 to 64. Since Ozempic was approved by the US Food and Drug Administration in 2020, prescriptions for the medication have more than tripled.
Credit: iStock
Researchers from the Indian Institute of Technology Madras (IIT Madras) and Christian Medical College (CMC), Vellore, have developed three artificial intelligence (AI)-based tools designed to help detect and assess kidney diseases earlier.
The technologies could help doctors identify kidney conditions more quickly, analyse medical images more consistently and assess the extent of kidney tumours in greater detail.
The team developed three complementary technologies:
Together, the tools have been designed to support clinicians in detecting kidney disease and assessing its severity.
Kidney diseases can remain asymptomatic during their early stages and may go undetected until significant damage has occurred.
The researchers say their AI-based tools could assist physicians by providing rapid and consistent analysis, potentially supporting earlier diagnosis and more informed treatment decisions.
“The team aimed to develop intelligent systems that would help clinicians make quicker and more informed decisions. We used machine learning along with clinical knowledge to develop tools that would assist in the earlier detection of kidney diseases and give more detailed information specific to the patient,” said Prof. G.L. Samuel, Department of Mechanical Engineering, IIT Madras, in a statement.
The CT image classifier was trained using more than 12,000 images and can distinguish between healthy kidneys, cysts, stones and tumours.
The researchers also developed a 3D imaging framework using open-source software to measure tumour burden.
According to the team, the approach offers an inexpensive and repeatable way to assess the extent of a tumour, which could provide additional information for treatment planning.
The CKD prediction model was implemented as a user-friendly prototype interface with the aim of facilitating future clinical translation. The team also worked on improving the model's accuracy and interpretability for doctors.
“Early detection is of paramount importance when dealing with kidney diseases; these AI tools can help detect at-risk patients early and plan their treatment more effectively. The patient-specific imaging framework is of significant promise as it goes beyond the standard measurements to give a more comprehensive picture of the extent of the disease,” said Jennifer Delighta, Research Scholar, IIT Madras.
The research could also contribute to the development of a kidney Digital Twin — a technology that combines AI-assisted image analysis with patient-specific 3D anatomical models.
Such virtual models could eventually help researchers and clinicians monitor disease progression, forecast changes and support more personalized treatment planning.
However, the technologies are still being developed. The researchers plan to test the models using additional patient datasets to validate their performance and establish partnerships with healthcare institutions for potential real-world deployment.
The team is also exploring the long-term integration of these AI technologies with minimally invasive wearable sensing systems and Digital Twin platforms for personalised kidney health monitoring.
Credit: AI Image
On September 3, 1928, Scottish scientist Alexander Fleming returned to his laboratory after a holiday. He famously noticed the antibacterial effect of mold contaminating a Staphylococcus culture.
Fleming identified the mold as belonging to the Penicillium genus and found that it produced a substance capable of inhibiting bacterial growth, which he named penicillin.
However, Fleming’s discovery was only the beginning. Penicillin proved difficult to isolate, purify and mass-produce. During World War II, scientists Howard Florey and Ernst Chain built on Fleming’s work to develop large-scale production methods, converting penicillin into a life-saving medicine and ushering in the modern antibiotic era.
As penicillin came into widespread medical use in the 1940s, resistance to the drug also emerged.
“Penicillin acts through a beta-lactam ring, which targets the bacteria, but then the organisms started producing an enzyme known as beta-lactamase,” Dr NK Ganguly, former Director General of the Indian Council of Medical Research (ICMR) told HealthandMe.
“This beta-lactamase broke the ring, so various derivative varieties of penicillins were synthesized,” he explained.
But as new penicillin derivatives were developed, bacteria also evolved or acquired mechanisms, including different beta-lactamases, that could break down these drugs.
As a result, penicillin became less effective against many bacteria. However, it remains effective against certain organisms and infections, including:
“Penicillin remains the gold standard for certain infections and indications, including neonatal sepsis, childhood pneumonia, rheumatic heart disease prophylaxis and resurging cases of syphilis,” Dr Ganguly said.
The story of penicillin resistance is an early example of a much broader problem the world is grappling with today: antimicrobial resistance (AMR), which threatens the effectiveness of modern healthcare.
Decades after antibiotics transformed medicine, the bacteria these drugs were designed to target have evolved significant resistance. This threat has been further compounded by the misuse and overuse of antibiotics across sectors.
According to the World Health Organization (WHO), approximately 1 in 6 laboratory-confirmed bacterial infections worldwide were resistant to antibiotic treatments in 2023.
Low- and middle-income countries bear the heaviest burden of infectious disease but face severe shortages of specialized antibiotics.
A global study covering 82 countries, led by the Murdoch Children’s Research Institute (MCRI), found that antibiotic resistance increased across every region between 2004 and 2022. As a result, critical treatments for routine childhood infections are becoming increasingly ineffective.
“The discovery of antibiotics is perhaps the most significant, life-changing breakthrough in the history of medicine,” Dr. Rajeev Jayadevan, Ex-President of IMA Cochin and Convener of the Research Cell, Kerala, told HealthandMe.
“However, bacteria possess natural evolutionary mechanisms to resist antibiotics as part of their survival machinery. Unfortunately, overuse in human healthcare, veterinary medicine and agriculture has allowed bacteria to continuously adapt and evade treatment,” he added.
Antimicrobial resistance is driven by a combination of clinical, agricultural, industrial and environmental factors:
So, are we running out of effective antibiotics? Not entirely, yet "the development of newer antibiotics has not kept pace with bacterial evolution" Dr Rajeev said.
Resistance is also making some infections increasingly difficult to treat. To counter, stronger national policies are needed the unnecessary antibiotic prescribing while ensuring that patients who genuinely need specialized antibiotics can access them.
Improving access will require coordinated action at both local and national levels. This includes:
“Beyond discovering new drugs, the long-term solution lies in regulating antibiotic use globally—because antimicrobial resistance knows no boundaries. A resistant organism originating in one region can rapidly spread worldwide,” Dr Rajeev said.
© $2026 Times Horizon Private Limited